PDC Therapeutics

Booth 1743
Epalinges, Vaud, Switzerland
PDC Therapeutics is a nanomedicines biotech company, developing targeted Polymer Drug Conjugates which provide cancer patients with an optimal therapeutic index. We are exploiting the proprietary and clinically validated platform technology of parent company RS Research, a clinical stage academic spin-off which has discovered a pioneering class of nanocarriers with a versatile targeting capability.

Our nanomedicine pipeline currently houses proprietary programs in various stages of preclinical and clinical development. We manufacture our products at our own GMP certificated production facility for clinical batch lyophilized oncology drugs. We look forward to leveraging our Sagitta™ nanocarrier platforms to enrich partners' pipelines by developing cutting-edge targeted therapies.